| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ADVANCED ACCELERATOR APPLIC | 14,400 | 385,000 | 0.10% | ||
| 2 | PARATEK PHARMACEUTICALS INC | 124,519 | 1,918,000 | 0.51% | ||
| 3 | ZOGENIX INC | 158,100 | 1,921,000 | 0.51% | ||
| 4 | AVIRAGEN THERAPEUTICS INC | 1,774,876 | 2,183,000 | 0.58% | ||
| 5 | INOTEK PHARMACEUTICALS CORP | 412,422 | 2,516,000 | 0.67% | ||
| 6 | ALDER BIOPHARMACEUTICALS INC | 124,570 | 2,591,000 | 0.69% | ||
| 7 | Arena Pharmaceuticals, Inc | 1,877,491 | 2,666,000 | 0.71% | ||
| 8 | ORTHOFIX INTL N V | 111,375 | 4,030,000 | 1.07% | ||
| 9 | CONCERT PHARMACEUTICALS INCORPORATED | 400,588 | 4,122,000 | 1.09% | ||
| 10 | NEURODERM LTD | 186,800 | 4,147,000 | 1.10% | ||
| 11 | Esperion Therapeutics Inc | 364,000 | 4,557,000 | 1.21% | ||
| 12 | FOAMIX PHARMACEUTICALS LTD | 550,997 | 6,116,000 | 1.62% | ||
| 13 | CORIUM INTERNATIONAL INC | 1,576,766 | 6,402,000 | 1.70% | ||
| 14 | AERIE PHARMACEUTICALS INC COM | 188,900 | 7,150,000 | 1.90% | ||
| 15 | ABBOTT LABS | 196,300 | 7,539,000 | 2.00% | ||
| 16 | MOMENTA PHARMACEUTICALS INC | 531,898 | 8,005,000 | 2.12% | ||
| 17 | MYRIAD GENETICS INC | 495,100 | 8,254,000 | 2.19% | ||
| 18 | CENTENE CORP DEL | 146,600 | 8,284,000 | 2.20% | ||
| 19 | Hercules Offshore Inc | 383,200 | 8,718,000 | 2.31% | ||
| 20 | RETROPHIN INC | 492,889 | 9,330,000 | 2.47% | ||
| 21 | MIMEDX GROUP INC COM | 1,245,550 | 11,035,000 | 2.93% | ||
| 22 | HALOZYME THERAPEUTICS INC | 1,225,444 | 12,107,000 | 3.21% | ||
| 23 | MALLINCKRODT PUB LTD CO | 306,500 | 15,270,000 | 4.05% | ||
| 24 | TESARO INCORPORATED | 142,300 | 19,136,000 | 5.07% | ||
| 25 | EXPRESS SCRIPTS HLDG CO | 447,001 | 30,749,000 | 8.15% | ||
| 26 | ANTHEM INC | 215,500 | 30,982,000 | 8.22% | ||
| 27 | ALLERGAN PLC | 158,700 | 33,329,000 | 8.84% | ||
| 28 | SHIRE PLC | 196,400 | 33,463,000 | 8.87% | ||
| 29 | LILLY ELI & CO | 547,405 | 40,261,000 | 10.68% | ||
| 30 | SANOFI | 1,234,200 | 49,911,000 | 13.24% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001164691-17-000037, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
